Oncopept Presentation at Novel Immunotherapeutics Summit 2016

Press

Medgenome to Present on Oncopept – a Point Solution in Cancer Immunotherapy at the Novel Immunotherapeutics Summit 2016

Our Analysis Reveals That Tongue and Buccal Cancers Harbor a set of Dual-purpose Tumor Neo-antigens That can be Used as Cancer Vaccines in a Therapeutic Setting, and as Biomarkers of Response to Select Patients for Cancer Immunotherapy

Boston-Business-Journal

Chicago-Business-Journal

marketwatch

seekingalpha

Yahoo_Finance

https://www.boston.com/tag/finance

http://www.marketwatch.com/story/medgenome-to-present-on-oncopept---a-point-solution-in-cancer-immunotherapy-at-the-novel-immunotherapeutics-summit-2016-2016-01-12

http://www.bizjournals.com/boston/prnewswire/press_releases/Georgia/2016/01/12/enUK201601121043?ana=prnew

http://www.bizjournals.com/chicago/prnewswire/press_releases/Georgia/2016/01/12/enUK201601121043?ana=prnews

https://finance.yahoo.com/news/medgenome-present-oncopept-point-solution-120000618.html

Considering Genomic Research?

Company

Resources

Research

Diagnostics

India

Contact